Skip to main content
Premium Trial:

Request an Annual Quote

MDS Lab Services Teams with UVic to Expand Proteomics Center in British Columbia

NEW YORK, March 17 - The University of Victoria, MDS Metro Laboratory Services, and Genome British Columbia signed an agreement on March 13 to expand the university's proteomics center on Vancouver Island.

 

The center, dubbed the UVic-Genome BC Proteomics Center, will be housed in over 20,000 square feet of space in the Vancouver Island Technology Park. MDS Metro, a subsidiary of MDS Inc., is relocating its Victoria analytical facilities to occupy around 17,000 square feet, while the existing UVic-Genome BC Proteomics Center will move from the University of Victoria campus to about 3,500 square feet of lab space adjoining MDS Metro.

 

The two groups plan to collaborate on new analytical tools for proteomics-based medical diagnostics and treatments.

 

The UVic-Genome BC Proteomics Center, formerly known as the UVic Protein Chemistry Center, has been providing protein chemistry services for the Canadian research community since 1982. Two years ago, the center's activities were expanded to provide proteomics support for large-scale research programs funded by Genome BC.

 

Further information on the planned center is available here.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.